EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Joint Analysis of Multiple Omics to Describe the Biological Characteristics of Resistant Hypertension

Shanshan Wang iD, Yuanlong Hu, Yuqi Wang, Yueyue Song, Dan Liang, Jiufeng Yin, Yunlun Li, Wenqing Yang, Dan Zhang

The Journal of Clinical Hypertension · 2025

DOI: 10.1111/jch.14961 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Hypertension, 2025. Verfasst von Shanshan Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Innovative Institute of Chinese Medicine and Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China. Hauptthemen laut MEDLINE: Hypertension, Metabolomics, Proteomics. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Key Project of Shandong Natural Science Foundation, Outstanding Youth Innovation Team of Shandong Institutions of Higher Learning, "Jinan University 20" innovation team project on blood circulation and blood vessel reconstruction.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Resistant hypertension (RH) may cause severe target organ damage and poses significant challenges in the field of hypertension prevention and treatment. Mining biological characteristics is crucial for exploring the pathogenesis of RH and for early diagnosis and treatment. Although several single‐omics studies have been conducted on RH, its complex pathogenesis has only been partially elucidated. In this study, metabolomics, proteomics, and transcriptomics were jointly analyzed in healthy subjects and patients with hypertension and RH. The multi‐omics analysis found that differential substances of RH were enriched in the HIF‐1 signaling pathway and that differential substances such as ascorbic acid, reduced glutathione (GSH), choline, citric acid, transferrin receptor (TfR), Egl‐9 family hypoxia‐inducible factor 2 (EGLN2), and glutathione peroxidase 1 (GPX1) were screened out. The results of intergroup comparisons were as follows: RH versus N: ascorbic acid (Fold Change (FC):0.42, p < 0.01), GSH (FC:0.65, p < 0.05), choline (FC:1.32, p < 0.05), citric acid (FC:0.48, p < 0.001), TfR (FC2.32, p < 0.001), GPX1 (FC:16.02, p < 0.001), EGLN2 (FC:0.76, p < 0.001); RH versus EH: ascorbic acid (FC:0.52, p < 0.05), GSH (FC:0.55, p < 0.05), choline (FC:1.28, p < 0.05), citric acid (FC:0.59, p < 0.001), TfR (FC:1.71, p < 0.001), GPX1 (FC:2.11, p < 0.05), EGLN2 (FC:0.76, p < 0.05). These differential substances may reflect the biology of RH. This study provides multi‐omics analysis for a deeper understanding of the complex molecular characteristics of RH, providing new insights into the pathogenesis, early diagnosis, and precise treatment of the disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypertensionMetabolomicsProteomicsHumansMaleFemaleMiddle AgedAdultGlutathioneTranscriptomeGlutathione PeroxidaseAscorbic AcidAged

Stichwörter der Autor:innen

biological characteristicsmultiple omicsresistant hypertension

Substanzen

GlutathioneGlutathione PeroxidaseAscorbic Acid

Autor:innen und Institutionen

  • Innovative Institute of Chinese Medicine and Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China.
  • Department of Cardiology, The Fifth People's Hospital of Jinan, Jinan, China.
  • First Faculty of Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
  • Shandong Engineering Laboratory of Traditional Chinese Medicine Precise Therapy for Cardiovascular Diseases, Jinan, China.
  • Department of Cardiology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.
  • Experimental Center, Shandong University of Traditional Chinese Medicine, Jinan, China.

ORCID-Profile: Shanshan Wang

Förderung

  • Key Project of Shandong Natural Science Foundation
  • Outstanding Youth Innovation Team of Shandong Institutions of Higher Learning
  • "Jinan University 20" innovation team project on blood circulation and blood vessel reconstruction

Zitieren

APA

Wang, S., Hu, Y., Wang, Y., Song, Y., Liang, D., Yin, J., Li, Y., Yang, W., & Zhang, D. (2025). Joint Analysis of Multiple Omics to Describe the Biological Characteristics of Resistant Hypertension. The Journal of Clinical Hypertension. https://doi.org/10.1111/jch.14961

Vancouver

Wang S, Hu Y, Wang Y, Song Y, Liang D, Yin J, et al. Joint Analysis of Multiple Omics to Describe the Biological Characteristics of Resistant Hypertension. The Journal of Clinical Hypertension. 2025. doi:10.1111/jch.14961

BibTeX
@article{Wang2025,
  author = {Wang, Shanshan and Hu, Yuanlong and Wang, Yuqi and Song, Yueyue and Liang, Dan and Yin, Jiufeng and Li, Yunlun and Yang, Wenqing and Zhang, Dan},
  title = {Joint Analysis of Multiple Omics to Describe the Biological Characteristics of Resistant Hypertension},
  journal = {The Journal of Clinical Hypertension},
  year = {2025},
  doi = {10.1111/jch.14961}
}
Kostenlos starten →